PTPRT and cancer: Second, most immuno-stimulators, such as MICB, MICA, CD80, ICOS, CD27, and various TNFSFs (all P < 0.05), were expressed at higher levels in PTPRD/PTPRT mutant cancers, compared with the WT (Figure 8C).